| Statement of Intent |
|
vii | |
| Introduction |
|
ix | |
|
Practice Guideline for the Psychiatric Evaluation of Adults |
|
|
1 | (28) |
|
|
|
5 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (2) |
|
General Psychiaric Evaluation |
|
|
7 | (1) |
|
|
|
7 | (1) |
|
|
|
8 | (1) |
|
|
|
9 | (1) |
|
Site of the Clinical Evaluation |
|
|
9 | (2) |
|
|
|
9 | (1) |
|
|
|
10 | (1) |
|
|
|
10 | (1) |
|
|
|
10 | (1) |
|
Domains of the Clinical Evaluation |
|
|
11 | (5) |
|
Reason for the Evaluation |
|
|
11 | (1) |
|
History of the Present Illness |
|
|
11 | (1) |
|
|
|
11 | (1) |
|
|
|
11 | (1) |
|
|
|
12 | (1) |
|
Psychosocial/Developmental History (Personal History) |
|
|
12 | (1) |
|
|
|
12 | (1) |
|
|
|
13 | (1) |
|
|
|
13 | (1) |
|
|
|
13 | (1) |
|
|
|
13 | (1) |
|
Mental Status Examination |
|
|
14 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
Information Derived From the Interview Process |
|
|
15 | (1) |
|
|
|
16 | (5) |
|
Methods of Obtaining Information |
|
|
16 | (3) |
|
The Process of Assessment |
|
|
19 | (2) |
|
|
|
21 | (2) |
|
Interactions With Third-Party Payers and Their Agents |
|
|
21 | (1) |
|
Privacy and Confidentiality |
|
|
22 | (1) |
|
Legal and Administrative Issues in Institutions |
|
|
22 | (1) |
|
Evaluation of Elderly Persons |
|
|
22 | (1) |
|
|
|
23 | (1) |
|
Individuals and Organizations That Submitted Comments |
|
|
24 | (2) |
|
|
|
26 | (3) |
|
Practice Guideline for the Treatment of Patients With Delirium |
|
|
29 | (38) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
Summary of Recommendations |
|
|
35 | (2) |
|
|
|
35 | (1) |
|
|
|
35 | (2) |
|
Disease Definition, Epidemiology, and Natural History |
|
|
37 | (6) |
|
Definition and Clinical Features |
|
|
37 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
39 | (1) |
|
|
|
40 | (1) |
|
|
|
41 | (2) |
|
Treatment Principles and Alternatives |
|
|
43 | (12) |
|
|
|
43 | (4) |
|
Environmental and Supportive Interventions |
|
|
47 | (2) |
|
|
|
49 | (6) |
|
Formulation and Implementation of a Treatment Plan |
|
|
55 | (2) |
|
|
|
55 | (1) |
|
Choice of Specific Environmental and Supportive Interventions |
|
|
55 | (1) |
|
Choice of Somatic Intervention |
|
|
56 | (1) |
|
Issues of Competency and Consent |
|
|
57 | (1) |
|
Clinical Features Influencing Treatment |
|
|
57 | (2) |
|
Comorbid Psychiatric Disorders |
|
|
57 | (1) |
|
Comorbid General Medical Conditions |
|
|
58 | (1) |
|
|
|
58 | (1) |
|
Reviewers and Reviewing Organizations |
|
|
59 | (1) |
|
|
|
60 | (7) |
|
Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias of Late Life |
|
|
67 | (70) |
|
|
|
71 | (1) |
|
|
|
72 | (1) |
|
Summary of Recommendations |
|
|
73 | (5) |
|
|
|
73 | (1) |
|
General Treatment Principles and Alternatives |
|
|
73 | (5) |
|
Disease Definition, Natural History, and Epidemiology |
|
|
78 | (5) |
|
|
|
78 | (1) |
|
|
|
79 | (1) |
|
|
|
79 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
81 | (2) |
|
Treatment Principles and Alternatives |
|
|
83 | (30) |
|
Determining the Site of Treatment and Frequency of Visits |
|
|
83 | (1) |
|
Psychiatric Management; Psychotherapy and Other Psychosocial Treatments |
|
|
84 | (8) |
|
Specific Psychotherapies/Psychosocial Treatments |
|
|
92 | (3) |
|
|
|
95 | (18) |
|
Development of a Treatment Plan |
|
|
113 | (3) |
|
|
|
114 | (1) |
|
Moderately Impaired Patients |
|
|
115 | (1) |
|
Severely and Profoundly Impaired Patients |
|
|
115 | (1) |
|
Factors Modifying Treatment Decisions |
|
|
116 | (6) |
|
|
|
116 | (1) |
|
|
|
117 | (3) |
|
Demographic and Social Factors |
|
|
120 | (2) |
|
|
|
122 | (1) |
|
Individuals and Organizations That Submitted Comments |
|
|
123 | (1) |
|
|
|
124 | (13) |
|
Practice Guideline for the Treatment of Patients With HIV/AIDS |
|
|
137 | (6) |
|
|
|
141 | (1) |
|
|
|
142 | (1) |
|
Part A: Background Information and Treatment Recommendations for Patients With HIV/AIDS |
|
|
143 | (41) |
|
Summary of Treatment Recommendations |
|
|
143 | (3) |
|
|
|
143 | (1) |
|
|
|
143 | (3) |
|
Disease Definition, Epidemiology, and Natural History |
|
|
146 | (16) |
|
Basic Facts About HIV Infection, AIDS, and Treatments |
|
|
146 | (9) |
|
Associated Features of Neuropsychiatric and Psychosocial Importance |
|
|
155 | (7) |
|
Prevalence of Comorbid Psychiatric Conditions |
|
|
162 | (1) |
|
Formulation and Implementation of a Treatment Plan |
|
|
162 | (14) |
|
Individuals at High Risk for HIV Infection |
|
|
162 | (5) |
|
|
|
167 | (9) |
|
Clinical and Environmental Features Influencing Treatment |
|
|
176 | (8) |
|
Sociodemographic Variables |
|
|
176 | (4) |
|
|
|
180 | (2) |
|
Special Treatment Situations |
|
|
182 | (2) |
|
Part B: Review and Synthesis of Available Evidence |
|
|
184 | (35) |
|
Data Regarding Prevention for Individuals at High Risk for HIV Infection |
|
|
184 | (6) |
|
HIV-Related Risk Assessment of Behavior |
|
|
184 | (1) |
|
|
|
184 | (1) |
|
Interventions to Reduce HIV Risk Behavior |
|
|
185 | (2) |
|
Reducing Maternal-Fetal Transmission |
|
|
187 | (1) |
|
|
|
188 | (1) |
|
Special Psychiatric Populations |
|
|
188 | (2) |
|
Data Regarding Psychiatric Treatments for Individuals With HIV Infection |
|
|
190 | (29) |
|
|
|
190 | (2) |
|
|
|
192 | (10) |
|
|
|
202 | (1) |
|
|
|
203 | (2) |
|
|
|
205 | (1) |
|
|
|
206 | (13) |
|
Part C: Future Research Needs |
|
|
219 | (36) |
|
Individuals and Organizations That Submitted Comments |
|
|
223 | (1) |
|
|
|
224 | (25) |
|
Practice Guideline for the Treatment of Patients With Schizophrenia, Second Edition |
|
|
249 | (6) |
|
Guide to Using This Practice Guideline |
|
|
253 | (1) |
|
|
|
254 | (1) |
|
Part A: Treatment Recommendations for Patients With Schizophrenia |
|
|
255 | (58) |
|
|
|
255 | (8) |
|
|
|
255 | (1) |
|
Formulation and Implementations of a Treatment Plan |
|
|
255 | (1) |
|
Establishing a Therapeutic Alliance |
|
|
256 | (1) |
|
|
|
256 | (2) |
|
|
|
258 | (1) |
|
|
|
259 | (2) |
|
Other Specific Treatment Issues |
|
|
261 | (2) |
|
Treatment Settings and Housing Options |
|
|
263 | (1) |
|
Formulation and Implementation of a Treatment Plan |
|
|
263 | (42) |
|
|
|
264 | (5) |
|
|
|
269 | (12) |
|
|
|
281 | (1) |
|
|
|
282 | (7) |
|
Special Issues in Caring for Patients With Treatment-Resistant Illness |
|
|
289 | (1) |
|
Clinical Features Influencing the Treatment Plan |
|
|
290 | (15) |
|
Treatment Settings and Housing Options |
|
|
305 | (8) |
|
Choice of Treatment Setting or Housing |
|
|
305 | (1) |
|
Common Treatment Settings |
|
|
305 | (8) |
|
Part B: Background Information and Review of Available Evidence |
|
|
313 | (60) |
|
Disease Definition, Natural History and Course, and Epidemiology |
|
|
313 | (5) |
|
|
|
313 | (3) |
|
Natural History and Course |
|
|
316 | (1) |
|
|
|
317 | (1) |
|
Review and Synthesis of Available Evidence |
|
|
318 | (55) |
|
Pharmacological Treatments |
|
|
318 | (40) |
|
|
|
358 | (3) |
|
Specific Psychosocial Interventions |
|
|
361 | (12) |
|
Part C: Future Research Directions |
|
|
373 | (76) |
|
Individuals and Organizations That Submitted Comments |
|
|
375 | (1) |
|
|
|
376 | (65) |
|
Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition |
|
|
441 | (8) |
|
Guide to Using This Practice Guideline |
|
|
445 | (1) |
|
|
|
446 | (1) |
|
|
|
447 | (2) |
|
Part A: Treatment Recommendations for Patients With Major Depressive Disorder |
|
|
449 | (31) |
|
Summary of Treatment Recommendations |
|
|
449 | (8) |
|
|
|
449 | (1) |
|
|
|
450 | (5) |
|
|
|
455 | (1) |
|
|
|
455 | (1) |
|
Discontinuation of Active Treatment |
|
|
456 | (1) |
|
Formulation and Implementation of a Treatment Plan |
|
|
457 | (11) |
|
|
|
457 | (3) |
|
|
|
460 | (6) |
|
|
|
466 | (1) |
|
|
|
467 | (1) |
|
Discontinuation of Active Treatment |
|
|
467 | (1) |
|
Specific Clinical Features Influencing the Treatment Plan |
|
|
468 | (12) |
|
|
|
468 | (4) |
|
Demographic and Psychosocial Variables |
|
|
472 | (6) |
|
Treatment Implications of Concurrent General Medical Disorders |
|
|
478 | (2) |
|
Part B: Background Information and Review of Available Evidence |
|
|
480 | (26) |
|
Disease Definition, Epidemiology, Natural History, and Course |
|
|
480 | (4) |
|
Specific Features of Diagnosis |
|
|
480 | (2) |
|
|
|
482 | (1) |
|
Natural History and Course |
|
|
483 | (1) |
|
Review and Synthesis of Available Evidence |
|
|
484 | (22) |
|
Acute Phase Somatic Treatments |
|
|
484 | (14) |
|
Acute Phase Psychosocial Interventions |
|
|
498 | (6) |
|
Psychotherapy Combined With Pharmacotherapy |
|
|
504 | (1) |
|
|
|
504 | (1) |
|
|
|
505 | (1) |
|
Part C: Future Research Needs |
|
|
506 | (27) |
|
Antidepressant Medications |
|
|
506 | (1) |
|
|
|
506 | (1) |
|
Electroconvulsive Therapy |
|
|
507 | (1) |
|
Other Treatment Modalities |
|
|
507 | (1) |
|
Individuals and Organizations That Submitted Comments |
|
|
508 | (1) |
|
|
|
508 | (17) |
|
Practice Guideline for the Treatment of Patients With Bipolar Disorder, Second Edition |
|
|
525 | (8) |
|
Guide to Using This Practice Guideline |
|
|
529 | (1) |
|
|
|
530 | (1) |
|
|
|
531 | (2) |
|
Part A: Treatment Recommendations for Patients With Bipolar Disorder |
|
|
533 | (20) |
|
Executive Summary of Recommendations |
|
|
533 | (3) |
|
|
|
533 | (1) |
|
|
|
533 | (2) |
|
|
|
535 | (1) |
|
Formulation and Implementation of a Treatment Plan |
|
|
536 | (9) |
|
|
|
537 | (4) |
|
|
|
541 | (3) |
|
|
|
544 | (1) |
|
Special Clinical Features Influencing the Treatment Plan |
|
|
545 | (8) |
|
|
|
545 | (2) |
|
Demographic and Psychosocial Factors |
|
|
547 | (5) |
|
Concurrent General Medical Conditions |
|
|
552 | (1) |
|
Part B: Background Information and Review of Available Evidence |
|
|
553 | (34) |
|
Disease Definition, Natural History and Course, and Epidemiology |
|
|
553 | (5) |
|
Definition of Bipolar Disorder |
|
|
553 | (1) |
|
Natural History and Course |
|
|
553 | (3) |
|
|
|
556 | (2) |
|
Review and Synthesis of Available Evidence |
|
|
558 | (29) |
|
Somatic Treatments of Acute Manic and Mixed Episodes |
|
|
558 | (13) |
|
Somatic Treatments of Acute Depressive Episodes |
|
|
571 | (5) |
|
|
|
576 | (1) |
|
|
|
577 | (4) |
|
Psychosocial Interventions |
|
|
581 | (4) |
|
Somatic Therapies for Children and Adolescents |
|
|
585 | (2) |
|
Part C: Future Research Needs |
|
|
587 | (166) |
|
|
|
587 | (1) |
|
|
|
588 | (1) |
|
|
|
588 | (1) |
|
|
|
588 | (1) |
|
|
|
588 | (1) |
|
|
|
589 | (1) |
|
Psychosocial Interventions |
|
|
589 | (24) |
|
Individuals and Organizations That Submitted Comments |
|
|
590 | (1) |
|
|
|
591 | (22) |
|
Practice Guideline for the Treatment of Patients With Panic Disorder |
|
|
613 | (62) |
|
|
|
617 | (1) |
|
|
|
618 | (1) |
|
Summary of Recommendations |
|
|
619 | (3) |
|
|
|
619 | (1) |
|
|
|
619 | (3) |
|
Disease Definition, Natural History, and Epidemiology |
|
|
622 | (2) |
|
Diagnosis of Panic Disorder |
|
|
622 | (1) |
|
Specific Features of Panic Disorder |
|
|
622 | (1) |
|
Natural History and Course |
|
|
623 | (1) |
|
Epidemiology and Associated Features |
|
|
623 | (1) |
|
Treatment Principles and Alternatives |
|
|
624 | (24) |
|
|
|
624 | (4) |
|
Interpreting Results From Studies of Treatments for Panic Disorder |
|
|
628 | (1) |
|
Specific Psychosocial Interventions |
|
|
629 | (6) |
|
Pharmacologic Interventions |
|
|
635 | (13) |
|
Development of a Treatment Plan for the Individual Patient |
|
|
648 | (5) |
|
Choosing a Site of Treatment |
|
|
648 | (1) |
|
Formulation of a Treatment Plan |
|
|
648 | (5) |
|
Clinical Features Influencing Treatment |
|
|
653 | (6) |
|
|
|
653 | (3) |
|
Concurrent General Medical Conditions |
|
|
656 | (1) |
|
|
|
657 | (2) |
|
|
|
659 | (2) |
|
Individuals and Organizations That Submitted Comments |
|
|
661 | (1) |
|
|
|
662 | (13) |
|
Practice Guideline for the Treatment of Patients With Eating Disorders, Second Edition |
|
|
675 | (70) |
|
|
|
679 | (3) |
|
|
|
679 | (1) |
|
|
|
679 | (3) |
|
Developing a Treatment Plan for the Individual Patient |
|
|
682 | (12) |
|
Choosing a Site of Treatment |
|
|
682 | (4) |
|
|
|
686 | (5) |
|
Choice of Specific Treatments for Anorexia Nervosa |
|
|
691 | (2) |
|
Choice of Specific Treatments for Bulimia Nervosa |
|
|
693 | (1) |
|
Disease Definition, Epidemiology, and Natural History |
|
|
694 | (9) |
|
|
|
694 | (4) |
|
Natural History and Course |
|
|
698 | (3) |
|
|
|
701 | (2) |
|
Treatment Principles and Alternatives |
|
|
703 | (16) |
|
Treatment of Anorexia Nervosa |
|
|
703 | (10) |
|
Treatment of Bulimia Nervosa |
|
|
713 | (6) |
|
Clinical and Environmental Features Influencing Treatment |
|
|
719 | (8) |
|
Other Important Clinical Features of Eating Disorders |
|
|
719 | (3) |
|
Other Psychiatric Factors |
|
|
722 | (1) |
|
Concurrent General Medical Conditions |
|
|
723 | (1) |
|
|
|
724 | (3) |
|
|
|
727 | (1) |
|
Individuals and Organizations That Submitted Comments |
|
|
728 | (1) |
|
|
|
729 | (16) |
|
Practice Guideline for the Treatment of Patients With Borderline Personality Disorder |
|
|
745 | (8) |
|
Guide to Using This Practice Guideline |
|
|
749 | (1) |
|
|
|
750 | (1) |
|
|
|
751 | (2) |
|
Part A: Treatment Recommendations for Patients With Borderline Personality Disorder |
|
|
753 | (35) |
|
Executive Summary of Recommendations |
|
|
753 | (4) |
|
|
|
753 | (1) |
|
|
|
753 | (1) |
|
Summary of Recommendations |
|
|
753 | (4) |
|
Formulation and Implementation of a Treatment Plan |
|
|
757 | (21) |
|
|
|
757 | (2) |
|
Principles of Psychiatric Management |
|
|
759 | (5) |
|
Principles of Treatment Selection |
|
|
764 | (1) |
|
Specific Treatment Strategies for the Clinical Features of Borderline Personality Disorder |
|
|
765 | (13) |
|
Special Features Influencing Treatment |
|
|
778 | (7) |
|
|
|
778 | (1) |
|
Problematic Substance Use |
|
|
778 | (1) |
|
Violent Behavior and Antisocial Traits |
|
|
779 | (1) |
|
Chronic Self-Destructive Behavior |
|
|
780 | (1) |
|
Childhood Trauma and PTSD |
|
|
780 | (2) |
|
|
|
782 | (1) |
|
|
|
783 | (1) |
|
|
|
784 | (1) |
|
|
|
784 | (1) |
|
|
|
785 | (1) |
|
|
|
785 | (3) |
|
|
|
785 | (1) |
|
|
|
786 | (1) |
|
Anger, Impulsivity, and Violence |
|
|
787 | (1) |
|
|
|
787 | (1) |
|
Part B: Background Information and Review of Available Evidence |
|
|
788 | (31) |
|
Disease Definition, Epidemiology, and Natural History |
|
|
788 | (4) |
|
Definition and Core Clinical Features |
|
|
788 | (2) |
|
|
|
790 | (1) |
|
|
|
791 | (1) |
|
|
|
791 | (1) |
|
Natural History and Course |
|
|
792 | (1) |
|
Review and Synthesis of Available Evidence |
|
|
792 | (27) |
|
Issues in Interpreting the Literature |
|
|
792 | (1) |
|
Review of Psychotherapy and Other Psychosocial Treatments |
|
|
793 | (12) |
|
Review of Pharmacotherapy and Other Somatic Treatments |
|
|
805 | (14) |
|
Part C: Future Research Needs |
|
|
819 | (22) |
|
|
|
819 | (1) |
|
Pharmacotherapy and Other Somatic Treatments |
|
|
820 | (15) |
|
Appendixes: Psychopharmacological Treatment Algorithms |
|
|
821 | (3) |
|
Individuals and Organizations That Submitted Comments |
|
|
824 | (1) |
|
|
|
825 | (10) |
|
Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors |
|
|
835 | (6) |
|
Guide to Using This Practice Guideline |
|
|
839 | (1) |
|
|
|
840 | (1) |
|
Part A: Assessment, Treatment, and Risk Management Recommendations |
|
|
841 | (67) |
|
Executive Summary of Recommendations |
|
|
841 | (7) |
|
Definitions and General Principles |
|
|
841 | (1) |
|
|
|
842 | (2) |
|
Estimation of Suicide Risk |
|
|
844 | (1) |
|
|
|
845 | (1) |
|
Specific Treatment Modalities |
|
|
846 | (2) |
|
Assessment of Patients With Suicidal Behaviors |
|
|
848 | (36) |
|
|
|
848 | (2) |
|
Conduct a Thorough Psychiatric Evaluation |
|
|
850 | (2) |
|
Specifically Inquire About Suicidal Thoughts, Plans, and Behaviors |
|
|
852 | (3) |
|
Establish a Multiaxial Diagnosis |
|
|
855 | (1) |
|
|
|
856 | (25) |
|
Additional Considerations When Evaluating Patients in Specific Treatment Settings |
|
|
881 | (3) |
|
|
|
884 | (13) |
|
Establish and Maintain a Therapeutic Alliance |
|
|
885 | (1) |
|
Attend to the Patient's Safety |
|
|
886 | (1) |
|
Determine a Treatment Setting |
|
|
886 | (4) |
|
Develop a Plan of Treatment |
|
|
890 | (1) |
|
Coordinate Care and Collaborate With Other Clinicians |
|
|
891 | (1) |
|
Promote Adherence to the Treatment Plan |
|
|
892 | (1) |
|
Provide Education to the Patient and Family |
|
|
893 | (1) |
|
Reassess Safety and Suicide Risk |
|
|
894 | (2) |
|
Monitor Psychiatric Status and Response to Treatment |
|
|
896 | (1) |
|
Obtain Consultation, if Indicated |
|
|
897 | (1) |
|
Specific Treatment Modalities |
|
|
897 | (5) |
|
|
|
897 | (4) |
|
|
|
901 | (1) |
|
Documentation and Risk Management |
|
|
902 | (6) |
|
General Risk Management and Documentation Issues Specific to Suicide |
|
|
902 | (2) |
|
Suicide Contracts: Usefulness and Limitations |
|
|
904 | (1) |
|
Communication With Significant Others |
|
|
905 | (1) |
|
Management of Suicide in One's Practice |
|
|
905 | (1) |
|
Mental Health Interventions for Surviving Family and Friends After a Suicide |
|
|
906 | (2) |
|
Part B: Background Information and Review of Available Evidence |
|
|
908 | (79) |
|
Review and Synthesis of Available Evidence |
|
|
908 | (79) |
|
Factors Altering Risk of Suicide and Attempted Suicide |
|
|
908 | (60) |
|
Psychiatric Assessment Techniques |
|
|
968 | (3) |
|
|
|
971 | (3) |
|
|
|
974 | (10) |
|
|
|
984 | (3) |
|
Part C: Future Research Needs |
|
|
987 | (42) |
|
Individuals and Organizations That Submitted Comments |
|
|
990 | (1) |
|
|
|
991 | (38) |
| Appendix: Practice Guideline Development Process |
|
1029 | (8) |
| Index |
|
1037 | |
Other versions by this Author
